Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Opravil

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2000
The SPICE study: 48-week activity of combinations of saquinavir soft gelatin and nelfinavir with and without nucleoside analogues. Study of Protease Inhibitor Combinations in EuropeG Moyle, A Pozniak, M Opravil, et al.
Lancet (London, England)|March 27, 1999
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort StudyB Ledergerber, M Egger, M Opravil, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1996
Rifabutin versus placebo in combination with three drugs in the treatment of nontuberculous mycobacterial infection in patients with AIDSB Dautzenberg, P Olliaro, B Ruf, et al.
AIDS (London, England)|November 4, 2000
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort StudyO T Rutschmann, P L Vernazza, H C Bucher, et al.
AIDS (London, England)|June 19, 1998
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort StudyO T Rutschmann, M Opravil, A Iten, et al.
JAMA|December 22, 1999
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort StudyB Ledergerber, M Egger, V Erard, et al.
Infection|December 31, 2004
Alveolar echinococcosis of the liver in an adult with human immunodeficiency virus type-1 infectionW Zingg, E C Renner-Schneiter, C Pauli-Magnus, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 9, 2000
Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV Cohort StudyM Opravil, R W Cone, M Fischer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort StudyK Boubaker, M Flepp, P Sudre, et al.
HIV Medicine|October 20, 2010
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort StudyJ Young, A U Scherrer, H F Günthard, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2000
The SPICE study: 48-week activity of combinations of saquinavir soft gelatin and nelfinavir with and without nucleoside analogues. Study of Protease Inhibitor Combinations in EuropeG Moyle, A Pozniak, M Opravil, et al.
Lancet (London, England)|March 27, 1999
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort StudyB Ledergerber, M Egger, M Opravil, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1996
Rifabutin versus placebo in combination with three drugs in the treatment of nontuberculous mycobacterial infection in patients with AIDSB Dautzenberg, P Olliaro, B Ruf, et al.
AIDS (London, England)|November 4, 2000
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort StudyO T Rutschmann, P L Vernazza, H C Bucher, et al.
AIDS (London, England)|June 19, 1998
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort StudyO T Rutschmann, M Opravil, A Iten, et al.
JAMA|December 22, 1999
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort StudyB Ledergerber, M Egger, V Erard, et al.
Infection|December 31, 2004
Alveolar echinococcosis of the liver in an adult with human immunodeficiency virus type-1 infectionW Zingg, E C Renner-Schneiter, C Pauli-Magnus, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 9, 2000
Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV Cohort StudyM Opravil, R W Cone, M Fischer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort StudyK Boubaker, M Flepp, P Sudre, et al.
HIV Medicine|October 20, 2010
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort StudyJ Young, A U Scherrer, H F Günthard, et al.
Pageof 12